Convergence Investment Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,511
Closed -$142K 256
2021
Q2
$142K Sell
2,511
-994
-28% -$56.6K 0.06% 243
2021
Q1
$185K Buy
+3,505
New +$191K 0.08% 216
2018
Q4
Sell
-22,734
Closed -$1.87M 352
2018
Q3
$1.87M Sell
22,734
-19,312
-46% -$1.53M 0.38% 96
2018
Q2
$3.29M Sell
42,046
-4,201
-9% -$325K 0.46% 84
2018
Q1
$3.41M Sell
46,247
-8,733
-16% -$620K 0.44% 85
2017
Q4
$3.75M Sell
54,980
-10,622
-16% -$687K 0.5% 67
2017
Q3
$4.03M Buy
65,602
+8,134
+14% +$499K 0.57% 40
2017
Q2
$3.61M Sell
57,468
-10,045
-15% -$573K 0.53% 49
2017
Q1
$3.75M Buy
67,513
+62,969
+1,386% +$3.24M 0.53% 47
2016
Q4
$217K Sell
4,544
-51,988
-92% -$2.91M 0.03% 301
2016
Q3
$3.66M Buy
+56,532
New +$3.18M 0.54% 45

Other funds holding NUS

Convergence Investment Partners's NUS Position: Q3 2021 in Review

Convergence Investment Partners sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 2,511 shares — an estimated $142K sold.

Convergence Investment Partners first reported a position in NUS in Q3 2016 and held it in 11 quarters. The position peaked at $4.03M in Q3 2017. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

  • Convergence Investment Partners reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
  • Convergence Investment Partners sold 2,511 Nu Skin shares in Q3 2021, an estimated $142K.
  • Convergence Investment Partners first reported a position in Nu Skin in Q3 2016 and held it in 11 quarters.
  • Convergence Investment Partners's Nu Skin position peaked at $4.03M in Q3 2017.
  • 246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Convergence Investment Partners's 13F filing for Q3 2021, filed 25 Oct 2021.